文献速递系统性红斑狼疮

未经治疗系统性红斑狼疮患者的肠道菌群呈现自身免疫原性和促炎特征

An Autoimmunogenic and Proinflammatory Profile Defined by the Gut Microbiota of Patients With Untreated Systemic Lupus Erythematosus.
PubMed 文献 · Arthritis Rheumatol · 2020-12-29

该研究对117例未经治疗SLE患者、52例治疗后SLE患者及115名匹配健康对照的粪便进行全基因组测序分析,并比较MRL/lpr小鼠粪便宏基因组。发现SLE患者肠道菌群组成与功能显著改变,部分菌种富集且治疗后减少,脂多糖生物合成增强而支链氨基酸生物合成降低,部分口腔来源菌种在肠道富集,微生物肽具有促炎能力。

要点

  • 未经治疗SLE患者肠道菌群组成和功能与健康对照显著不同。
  • 部分菌种在SLE肠道富集且治疗后减少,脂多糖合成增强。
  • 部分口腔来源菌种在SLE肠道富集,微生物肽具促炎能力。

核心结论

  • 未经治疗SLE患者肠道菌群具有自身免疫原性和促炎特征,改变微生物组可能为SLE提供辅助治疗。

研究设计与样本

  • 研究纳入117例未经治疗SLE患者、52例治疗后SLE患者和115名匹配健康对照,进行粪便全基因组测序分析,并比较MRL/lpr小鼠粪便宏基因组。

主要发现

  • SLE患者肠道菌群组成和功能与健康对照显著不同,部分菌种如Clostridium species ATCC BAA-442、Atopobium rimae等在SLE肠道富集且治疗后减少。
  • SLE患者肠道中脂多糖生物合成增强,支链氨基酸生物合成降低,小鼠 findings 与人类一致。
  • 部分口腔来源菌种在SLE患者肠道富集,来自SLE富集菌种的某些微生物肽具有促炎能力。

临床怎么用

  • 微生物组改变策略可能作为SLE的辅助治疗,但需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Changes in gut microbiota have been linked to systemic lupus erythematosus (SLE), but knowledge is limited. Our study aimed to provide an in-depth understanding of the contribution of gut microbiota to the immunopathogenesis of SLE. METHODS: Fecal metagenomes from 117 patients with untreated SLE and 52 SLE patients posttreatment were aligned with 115 matched healthy controls and analyzed by whole-genome profiling. For comparison, we assessed the fecal metagenome of MRL/lpr mice. The oral microbiota origin of the gut species that existed in SLE patients was documented by single-nucleotide polymorphism-based strain-level analyses. Functional validation assays were performed to demonstrate the molecular mimicry of newly found microbial peptides. RESULTS: Gut microbiota from individuals with SLE displayed significant differences in microbial composition and function compared to healthy controls. Certain species, including the Clostridium species ATCC BAA-442 as well as Atopobium rimae, Shuttleworthia satelles, Actinomyces massiliensis, Bacteroides fragilis, and Clostridium leptum, were enriched in SLE gut microbiota and reduced after treatment. Enhanced lipopolysaccharide biosynthesis aligned with reduced branched chain amino acid biosynthesis was observed in the gut of SLE patients. The findings in mice were consistent with our findings in human subjects. Interestingly, some species with an oral microbiota origin were enriched in the gut of SLE patients. Functional validation assays demonstrated the proinflammatory capacities of some microbial peptides derived from SLE-enriched species. CONCLUSION: This study provides detailed information on the microbiota of untreated patients with SLE, including their functional signatures, similarities with murine counterparts, oral origin, and the definition of autoantigen-mimicking peptides. Our data demonstrate that microbiome-altering approaches may offer valuable adjuvant therapies in SLE.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Chen BD, Jia XM, Xu JY, et al. An Autoimmunogenic and Proinflammatory Profile Defined by the Gut Microbiota of Patients With Untreated Systemic Lupus Erythematosus. Arthritis Rheumatol. 2020. PMID: 33124780. doi:10.1002/art.41511

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。